CDC diagnostic tests for COVID-19

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Up-to-date Information

Up-to-Date Info: To find the latest CDC information on this topic go to: https://www.cdc.gov/coronavirus/2019-nCoV/index.html

CDC diagnostic tests for COVID-19

Aug. 7, 2021
By National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.

[PDF-8.92 MB]

Select the Download button to view the document

This document is over 5mb in size and cannot be previewed

English

Details Supporting Files You May Also Like

Details:

Corporate Authors:

National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases.
Description:

Updated Aug. 7, 2021

CDC has developed two laboratory tests that identify SARS-CoV-2, the virus that causes COVID-19. The first test for COVID-19 diagnosis that CDC distributed, released in February 2020, is the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, a test that accurately detects SARS-CoV-2 in respiratory specimens. CDC released a second assay in July 2020, the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, which permits public health laboratories to run three tests in a single reaction well. The Flu SC2 Multiplex is more efficient in its use of test reagents, allows higher throughput, and simultaneously gives accurate results about the presence of SARS-CoV-2, influenza A, and influenza B nucleic acid in a patient specimen. Symptoms for COVID-19 and the Flu can be similar, so testing for all three viruses at the same time will provide public health officials with information they need to help reduce the spread of these viruses in the community while conserving resources that are in short supply.

Please note: CDC will discontinue the CDC 2019-nCoV Real-time RT-PCR Diagnostic Panel at the end of 2021. For more details, please see the CDC 2019-nCoV Real-time RT-PCR Diagnostic Panel section below.
Content Notes:

CDC Influenza SARS-CoV-2 Multiplex Assay -- CDC 2019-nCoV RT-PCR Diagnostic Panel -- Who Can Use These Tests?
Subjects:

[+]

Betacoronavirus Clinical Laboratory Techniques Coronavirus Infections/diagnosis COVID-19 Diagnostic Tests, Routine Laboratories Pneumonia, Viral/diagnosis Reagent Kits, Diagnostic Real-Time Polymerase Chain Reaction Serologic Tests
Document Type:

Webpage
Collection(s):

Stephen B. Thacker CDC Library collection
Main Document Checksum:

[+]

urn:sha256:85a58a5c521edcb73d342e5925cd4469c08f1072cc45b261e11014ced46b3d4f
Download URL:

https://stacks.cdc.gov/view/cdc/108676/cdc_108676_DS1.pdf
File Type:

testing.html

htm

More +